Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.
Chantarogh S, Vilaiyuk S, Tim-Aroon T, Worawichawong S.
BMC Nephrol. 2017 May 12;18(1):159. doi: 10.1186/s12882-017-0573-y.
Osteo-articular manifestations of amyloidosis.
M'bappé P, Grateau G.
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):459-75. doi: 10.1016/j.berh.2012.07.003.
From arthritis to Alzheimer's disease: current concepts on the pathogenesis of amyloidosis.
Kisilevsky R.
Can J Physiol Pharmacol. 1987 Sep;65(9):1805-15. doi: 10.1139/y87-282.
Amyloidosis and rheumatoid arthritis.
Husby G.
Clin Exp Rheumatol. 1985 Apr-Jun;3(2):173-80.
Amyloidosis as a cause of death in patients with rheumatoid arthritis.
Koivuniemi R, Paimela L, Suomalainen R, Leirisalo-Repo M.
Clin Exp Rheumatol. 2008 May-Jun;26(3):408-13.
Successful Treatment of Rheumatoid Arthritis-Associated Renal AA Amyloidosis with Tocilizumab.
Kovács A, Cserenyecz A, Baksay B, Kemény É, Szekanecz Z.
Isr Med Assoc J. 2020 Jul;22(7):455-457.
Clinical outcomes of secondary amyloidosis in inflammatory arthritis: A case series from Western India.
Kadam S, Sachdev G, Balakrishnan C, Yadav S, Patil P, Patankar A, Swain B.
Int J Rheum Dis. 2024 Jun;27(6):e15227. doi: 10.1111/1756-185X.15227.
Prevalence of secondary amyloidosis in Asian North Indian patients with rheumatoid arthritis.
Wakhlu A, Krisnani N, Hissaria P, Aggarwal A, Misra R.
J Rheumatol. 2003 May;30(5):948-51.
[Causes and treatment of systemic amyloidosis].
Blank N, Hegenbart U, Schönland S.
Z Rheumatol. 2016 Mar;75(2):141-50. doi: 10.1007/s00393-015-0024-8.
[A case of rheumatoid arthritis with secondary amyloidosis in urinary bladder].
Nakayamada S, Saito K, Nakatsuka K, Nakano K, Tokunaga M, Tsujimura S, Ota T, Tanaka Y.
Ryumachi. 2002 Jun;42(3):618-23.
